Everolimus-eluting bioresorbable vascular scaffolds for treatment of patients presenting with ST-segment elevation myocardial infarction: BVS STEMI first study

R. Diletti, A. Karanasos, T. Muramatsu, S. Nakatani, N. M. Van Mieghem, Y. Onuma, S. T. Nauta, Y. Ishibashi, M. J. Lenzen, J. Ligthart, C. Schultz, E. Regar, P. P. de Jaegere, P. W. Serruys, F. Zijlstra, R. J. van Geuns
  • European Heart Journal, January 2014, European Society of Cardiology
  • DOI: 10.1093/eurheartj/eht546
The author haven't finished explaining this publicationThe author haven't finished explaining this publication
The following have contributed to this page: Dr E Regar

In partnership with: